Nanobiotix: Today's Data Readout For Radiation Therapy Enhances Bull Case (NASDAQ:NBTX)

Nanobiotix S.A. stock surges on promising cancer trial results and major partnership. Click for more on NBTX stock and why I'm bullish on this microcap.